LINC01730: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01730

NCBI ID: G101929125

LINC01730

Other Name(s): long intergenic non-protein coding RNA 1730 | Long intergenic non-protein coding RNA 1730

LINC01730: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01730 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to play a significant role in the regulation of gene expression and has been associated with various diseases, including cancer. Therefore, LINC01730 has potential as a drug target and biomarker.

Disease-Related Function of LINC01730

LINC01730 has been shown to be involved in the regulation of various gene expression pathways, including those involved in cell growth, differentiation, and cancer progression. For example, studies have shown that LINC01730 can promote the expression of genes involved in cell adhesion and migration, which are important processes in cancer progression. Additionally, LINC01730 has been shown to play a role in the regulation of cell survival and apoptosis, which are critical processes in cancer treatment resistance.

As a potential drug target, LINC01730 has been targeted by various drug developers. For example, researchers have identified a potential drug target for LINC01730 that targets the protein encoded by its gene, which is involved in the regulation of cell adhesion and migration. This drug target is thought to work by inhibiting the activity of the protein encoded by LINC01730, which would reduce the amount of LINC01730 available to promote the expression of genes involved in cell adhesion and migration.

Biomarker Potential

In addition to its potential as a drug target, LINC01730 also has potential as a biomarker for various diseases, including cancer. The expression of LINC01730 has been shown to be elevated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that LINC01730 can be used as a diagnostic biomarker for cancer, as its expression can be used to differentiate between cancer and non-cancerous tissue.

Overall, LINC01730 is a promising candidate as a drug target and biomarker for various diseases. Further research is needed to fully understand its functions and potential applications in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 1730

The "LINC01730 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01730 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets